Osaic Holdings’s Creative Medical Technology CELZ Stock Holding History

Osaic Holdings’s Portfolio CELZ Stock Details CELZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,130	Closed	-$2.21K	–	7848
2025 Q4	$2.21K	Hold	1,130	–	–	﹤0.01%	7062
2025 Q3	$3.61K	Hold	1,130	–	–	﹤0.01%	6921
2025 Q2	$2.99K	Sell	1,130 -131	-10%	-$282	﹤0.01%	6796
2025 Q1	$2.74K	Buy	1,261 +1,130	+863%	+$3.94K	﹤0.01%	6475
2024 Q4	$302	Buy	131 +30	+30%	+$91	﹤0.01%	7122
2024 Q3	$313	Hold	101	–	–	﹤0.01%	7094
2024 Q2	$389	Buy	101 +100	+10,000%	+$452	﹤0.01%	7046
2024 Q1	$5	Hold	1	–	–	﹤0.01%	7157
2023 Q4	$5	Sell	1 -2	-67%	-$9	﹤0.01%	7253
2023 Q3	$15	Buy	3 +1	+50%	+$5	﹤0.01%	7328
2023 Q2	$9	Buy	2 +1	+100%	+$6	﹤0.01%	7406
2023 Q1	$6	Hold	1	–	–	﹤0.01%	7462
2022 Q4	$0	Hold	1	–	–	﹤0.01%	7202
2022 Q3	$0	Hold	1	–	–	﹤0.01%	7280
2022 Q2	$0	Buy	+1	New	+$16	﹤0.01%	7362
2022 Q1	–	Sell	-1	Closed	–	–	7263
2021 Q4	$0	Buy	+1	New	+$21	﹤0.01%	7396

Other funds holding CELZ

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Osaic Holdings's CELZ Position: Q1 2026 in Review

Osaic Holdings sold out of Creative Medical Technology (CELZ) in Q1 2026, closing a stake of 1,130 shares — an estimated $2.21K sold.

Osaic Holdings first reported a position in CELZ in Q4 2021 and held it in 16 quarters. The position peaked at $3.61K in Q3 2025. 11 funds tracked by Wall St. Rank hold CELZ as of Q1 2026.

Osaic Holdings reported no remaining Creative Medical Technology position as of Q1 2026 after selling out during the quarter.
Osaic Holdings sold 1,130 Creative Medical Technology shares in Q1 2026, an estimated $2.21K.
Osaic Holdings first reported a position in Creative Medical Technology in Q4 2021 and held it in 16 quarters.
Osaic Holdings's Creative Medical Technology position peaked at $3.61K in Q3 2025.
11 funds tracked by Wall St. Rank held Creative Medical Technology as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.